Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (PIVO Pro): An Adaptive Group Sequential Randomized Controlled Trial (The PIVO Trial)

NCT06806709 is registered in ClinicalTrials.gov with The University of Queensland as lead sponsor.

NCT NCT06806709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06806709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (PIVO Pro): An Adaptive Group Sequential Randomized Controlled Trial (The PIVO Trial)
Lead sponsor
The University of Queensland
Phase
Not applicable
Overall status
Recruiting
Start date
August 18, 2025
Completion date
December 31, 2026
Enrollment
1,148 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

blood culture contamination, infection